Techno Trends
Techno Trends includes advancements and innovations in pharmaceutical products and technology from around the world. Additionally, you may keep abreast of any recent advancements in the pharmaceutical industry (product information and technological trends).
Dyne Therapeutics’ DYNE-251 Receives FDA Breakthrough Therapy Designation
Dyne Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to DYNE-251 for Duchenne muscular dystrophy (DMD) patients amenable...
Bon Natural Life Launches Breakthrough AI-Powered Drug Discovery Platform
Bon Natural Life Limited has officially launched its artificial intelligence (AI)-driven drug research and development (R&D) division. ...
Lexeo Therapeutics Receives Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia
Lexeo Therapeutic has received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for its investigational treatment LX2006. ...
Ultragenyx Receives FDA Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) has been granted Breakthrough Therapy Designation by the United States Food and Drug Administration (FDA) for its investigational treatment GTX-102 (apazunersen) for Angelman syndrome....
Chai Discovery Introduces Breakthrough in AI-Driven Antibody Design
Chai Discovery has announced a major advance in de novo antibody design with its latest AI model, Chai-2. The model achieves a design hit rate of nearly 20%, a significant leap from the sub-0.1% rates seen with traditional and AI-based methods....
FDA Approves Revolution Medicines’ Breakthrough Therapy Daraxonrasib for Pancreatic Cancer
Revolution Medicines has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to daraxonrasib....
ImmunoPrecise Announces Breakthrough in Dengue Vaccine Research Using LENSai™ Platform
ImmunoPrecise Antibodies Ltd has announced a significant breakthrough in dengue vaccine research. Using its proprietary LENSai™ platform, powered by patented HYFT® technology, the company has discovered an epitope conserved...
Sandoz Launches First Interchangeable Denosumab Biosimilars in the US
Sandoz has launched WYOST® and Jubbonti® (denosumab-bbdz) in the United States, marking the availability of the first interchangeable biosimilars to Amgen’s XGEVA® and Prolia®....
FDA Grants Breakthrough Therapy Designation to Rezolute’s Ersodetug for Hypoglycemia
Rezolute has announced Breakthrough Therapy Designation from the U.S. Food and Drug Administration for ersodetug. The designation applies to the treatment of hypoglycaemia caused by tumor-induced hyperinsulinism (HI)....
FDA Approves Alnylam’s First-of-its-Kind Drug AMVUTTRA® to Prevent Heart-Related Deaths
Alnylam Pharmaceuticals has received approval from the U.S. Food and Drug Administration for a supplemental New Drug Application for AMVUTTRA® (vutrisiran). The decision allows AMVUTTRA to be used in the treatment of cardiomyopathy linked...
